B. Riley’s Top Biotech Pick: 4D Molecular Therapeutics B. Riley Names 4D Molecular Therapeutics a Top Biotech Pick B. Riley Securities has reaffirmed 4D Molecular Therapeutics (NASDAQ: FDMT) a... September 30, 2026 Read Guide →
